There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper care can keep your kidneys healthy for years. FSGS treatment that includes an early diagnosis, personalized treatment, ...
Please provide your email address to receive an email when new articles are posted on . Researchers identified functionally relevant risk factors for pediatric primary focal segmental ...
Boehringer Ingelheim today announced results from a 12-week Phase II clinical trial evaluating apecotrep (BI 764198), an oral, potential first-in-class, non-immunosuppressive TRPC6 inhibitor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results